Why is Zenith falling/rising?

As of 30-Jun, Zenith Drugs Ltd is experiencing a price increase, with its current price at 71.40, reflecting a rise of 3.4 or 5.0%. The stock has outperformed its sector today by 4.31%. In terms of returns, the stock has shown a positive performance over the past week, gaining 6.41%, while it has underperformed over the past month with a decline of 6.05%. The stock is currently trading above its 5-day and 20-day moving averages, although it remains below its longer-term moving averages of 50-day, 100-day, and 200-day. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 18.37% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.
Broader Market Context: In the context of the broader market, Zenith's short-term return of 6.41% over the past week significantly outpaces the Sensex, which has only increased by 2.18% in the same period. However, the stock's year-to-date performance remains negative at -11.63%, contrasting with the Sensex's positive return of 7.92%. This suggests that while the stock is currently experiencing a short-term rally, its longer-term performance has been less favorable compared to the benchmark, indicating potential volatility and investor caution moving forward.